Related Experiment Video
Updated: Mar 22, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Olmesartan-induced enteropathy associated with cutaneous lesions
Nassim Hammoudi1, Marie Dior1, Vincent Giraud2
1Department of Gastroenterology Louis Mourier Teaching Hospital Colombes France; Denis Diderot University Paris 7 Paris France.
Abstract:
Olmesartan is an angiotensin II receptor antagonist which may cause severe sprue-like enteropathy with duodenal villous atrophy. Skin lesions may be associated as reported for the first time in our case. Clinicians should be informed of this side effect and its reversibility after suspension of the drug.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease II: Clinical Manifestations
Drugs for Treatment of Ulcerative Colitis in IBD
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Endocarditis II: Clinical Features of Infective Endocarditis
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

